Investigating how glucocorticoids affect oral cancer and exploring a natural compound for treatment
The oral glucocorticoid system in oral carcinogenesis and its modulation for improved treatment outcomes
This study is looking at how certain medications called glucocorticoids might sometimes help oral cancer grow instead of fighting it, and it will also explore a natural substance called gallic acid that could improve treatment options for people with oral cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11182654 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of glucocorticoids in the development and spread of oral cancer. It aims to explore how these compounds, often used in treatment, may sometimes promote tumor growth instead of preventing it. The study will also investigate a natural compound called gallic acid, which has shown promise in modifying glucocorticoid metabolism, potentially leading to better treatment strategies for oral cancer. By examining these mechanisms, the research seeks to identify new approaches for preventing and treating oral cancer effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with oral cancer or those at high risk for developing oral cancer.
Not a fit: Patients with oral cancer who are not eligible for adjuvant therapy or those with advanced metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients with oral cancer, potentially enhancing survival rates and quality of life.
How similar studies have performed: Previous research has shown promise in using natural compounds for cancer prevention, suggesting that this approach may yield beneficial results.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Oghumu, Steve Onyeka — Ohio State University
- Study coordinator: Oghumu, Steve Onyeka
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.